BRIEF-Glaxo ADRs up 2 pct after FDA advisory panel votes

NEW YORK, April 17 Wed Apr 17, 2013 2:30pm EDT

Related Topics

NEW YORK, April 17 (Reuters) - Glaxosmithkline Plc: * U.S.-traded shares up 2 percent after FDA advisory panel votes

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.